Systematic review / meta-analysis / 2014
Higher vitamin D levels were linked to lower mortality in cancer patients.
A meta-analysis of prospective cohort studies examined 2,330 colorectal cancer patients and 4,413 breast cancer patients across ten studies. Comparing highest to lowest 25-hydroxyvitamin D categories, pooled hazard ratios were 0.71 (95% CI 0.55-0.91) for overall mortality and 0.65 (95% CI 0.49-0.86) for disease-specific mortality in colorectal cancer. In breast cancer, corresponding hazard ratios were 0.62 (95% CI 0.49-0.78) and 0.58 (95% CI 0.38-0.84).
Shows an association, not proof of cause and effect.
- Study type
- Meta-analysis of prospective cohort studies
- Who was studied
- 2,330 colorectal and 4,413 breast cancer patients (10 cohort studies)
- What was measured
- Overall and disease-specific mortality
THE PAPER
Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies.
Maalmi H, Ordóñez-Mena JM, Schöttker B, Brenner H. Eur J Cancer, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.